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ABSTRACT
CHD3 and CHD4 (Chromodomain Helicase DNA bind-
ing protein), two highly similar representatives of the
Mi-2 subfamily of SF2 helicases, are coexpressed in
many cell lines and tissues and have been reported
to act as the motor subunit of the NuRD complex
(nucleosome remodeling and deacetylase activities).
Besides CHD proteins, NuRD contains several re-
pressors like HDAC1/2, MTA2/3 and MBD2/3, argu-
ing for a role as a transcriptional repressor. However,
the subunit composition varies among cell- and tis-
sue types and physiological conditions. In particular,
it is unclear if CHD3 and CHD4 coexist in the same
NuRD complex or whether they form distinct NuRD
complexes with specific functions. We mapped the
CHD composition of NuRD complexes in mammalian
cells and discovered that they are isoform-specific,
containing either the monomeric CHD3 or CHD4 AT-
Pase. Both types of complexes exhibit similar in-
tranuclear mobility, interact with HP1 and rapidly ac-
cumulate at UV-induced DNA repair sites. But, CHD3
and CHD4 exhibit distinct nuclear localization pat-
terns in unperturbed cells, revealing a subset of spe-
cific target genes. Furthermore, CHD3 and CHD4 dif-
fer in their nucleosome remodeling and positioning
behaviour in vitro. The proteins form distinct CHD3-
and CHD4-NuRD complexes that do not only repress,
but can just as well activate gene transcription of
overlapping and specific target genes.
INTRODUCTION
In eukaryotes the nuclear DNA is organized in form of
chromatin. A nucleosome, in which 147 bp of double-
stranded DNA are wrapped in a left-handed helix around
a histone octamer, represents the smallest structural unit of
chromatin. On the one hand this organization compacts the
DNA and on the other hand it causes accessibility prob-
lems forDNA-dependent processes like transcription, repli-
cation or DNA repair. To circumvent such chromatin me-
diated repression, eukaryotic cells are able to modify chro-
matin structure by post translational modifications (PTMs)
of histones (1), DNAmodifications (2) or the association of
RNA with chromatin (34). In addition, cells possess chro-
matin remodeling enzymes, which are able to move, evict
or rearrange nucleosomes upon hydrolysis of ATP (5). In
vivo, many remodeling enzymes act in the context of protein
complexes, comprising up to 10 subunits ormore, which can
modify and control the activity and behaviour of those en-
zymes (6,5).
Nucleosome remodeling enzymes possess a helicase-like
region of similar primary sequence to Saccharomyces cere-
visiae Snf2p, placing them among the Snf2 family of the so
called helicase-like superfamily 2 (SF2) (7). Beside the com-
mon ATPase domain, remodelers possess diverse unique
domains (5). In combination with biochemical assays and
sequence analyses, the individual domain composition of a
remodeler forms the basis to classify the diverse enzymes
into 24 Snf2 subfamilies (7,8). Up to now, there are 53 Snf2
proteins listed in total (9). Among those proteins are diverse
isoforms and highly identical proteins: hBrm and hBrg1
[Snf2 subfamily], hSnf2h, hSnf2l, hSnf2l+13, yeast Isw1p
and Isw2p [Iswi subfamily] or hCHD3 and hCHD4 [Mi-2
subfamily] (10–13). This raises the question about the func-
tional differences between those enzymes. Why do cells in-
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vest so much effort in the expression of so many enzymes
which are very similar regarding their sequence?
Notably, human Brg1 and Brm, two SWI-SNF2 ho-
mologswith 75% sequence identity (13) were found to reside
in separate complexes, named Numac (Brg1), PBaf (Brg1)
or Baf (Brg1 or Brm) (14–17), suggesting specific roles for
each of the two enzymes. Indeed, experiments in mouse
showed that Brg1-null mice die already at periimplanta-
tion stage (18,19), whereas Brm-null mice only exhibit mi-
nor defects like increased body weight (20,19). Similar to
Brg1 and Brm, two representatives of the Iswi subfamily,
named Snf2h and Snf2l, were also found in distinct com-
plexes (17). Human and mouse Snf2h were found in most
of the Iswi complexes, i.e. in WCRF, a complex compris-
ing hSnf2h with subunits of Cohesin and NuRD complex,
hACF, hRSF, hCHRAC (predominantly Snf2h but as well
Snf2l), mNoRC and mCERF (Snf2h or Snf2l, cell type de-
pendent) (21–29). Up to now, hNURF is the only complex
reported to contain exclusively hSnf2l as the motor sub-
unit (30). In correlation with the presence of human Snf2h/l
(80% sequence identity) (31) in distinct chromatin remodel-
ing complexes the murine homologs, mSnf2h and mSnf2l
(83% overall identity) (10) were reported to exert distinct
roles at specific time points during development (10,32).
FurthermoremSnf2h is expressed ubiquitously, whereas the
expression of mSnf2l seems to be restricted to the brain and
gonadal tissues (10).
In contrast to the examples mentioned above, the highly
similar Mi-2 subfamily members hCHD3 and hCHD4
(71.6% amino acid identity) (Figure 1A and Supplemen-
tary Figure S1 and (11)) were both described to act solely
in the context of NuRD, a protein complex that comprises
both nucleosome remodeling and deacetylase activities (33–
37). Beside the CHD proteins, which represent the motor
subunit of the complex (38), proteins such as MTA1/2/3,
MBD2/3, HDAC1/2, RBBP4/7 (RbAp48/46), p66α or
p66β have been reported to be core subunits of the NuRD
complex (33–38). Since several of those core subunits are as-
sociated with transcriptional repression, NuRD is thought
to act mainly as a transcriptional repressor (37–39). In-
terestingly, different physiological conditions or different
cell/tissue types seem to influence the subunit composition
of NuRD complexes (38).
CHD3 (also named Mi-2 alpha) and CHD4 (also
named Mi-2 beta) are dermatomyositis specific autoanti-
gens (40,41). Their common association with NuRD core
subunits and the fact that both enzymes are coexpressed
in many cell lines and tissues (Supplementary Figure S2)
suggests that they might exert similar functions. Up to
now, there are only functional studies available character-
izing one of the two Mi-2 isoforms. Furthermore, it is also
still controversial, whether CHD3 and CHD4 coexist in
the same NuRD complex or if they form isoform-specific
NuRD complexes (37,42,43).
In the present study, we therefore focused on two aspects:
mapping the CHD composition in NuRD complexes in liv-
ing cells and comparing both remodeling enzymes in sev-
eral in vitro and live cell assays. Combining biochemical
and microscopy based techniques, we report here a func-
tional comparison of the CHD3 and CHD4 isoforms with
the following findings: (i) NuRD complexes in mammalian
cells are isoform-specific: They contain only one of the two
types of motor proteins, which seem to be associated with
the chromatin remodeling complex as monomers. (ii) These
isoform-specific NuRD complexes exhibit similar mobility
within the nucleoplasm, interact withHP1 and are recruited
to laser-induced DNA repair sites within two minutes. Nev-
ertheless, CHD3 and CHD4 exhibit differential nuclear lo-
calization patterns in unperturbed cells. (iii) Recombinant
CHD3 and CHD4 show differences in their remodeling be-
haviour on reconstituted chromatin. (iv) Both CHD pro-
teins seem to regulate the transcription of distinct genes.
Taken together our data therefore suggest that CHD3 and
CHD4 form separate NuRD complexes with common and
distinct biological functions.
MATERIALS AND METHODS
Plasmids and cloning
The cDNA sequences for hCHD3 (UniProt: Q12873)
and hCHD4 (UniProt Q14839) were subcloned into
pDONR™221 (Life Technologies) according to the BP
recombination protocol from the Gateway® Technol-
ogy manual (Life Technologies). The cDNA encoding
hCHD3 was a kind gift from Prof. O.S. Gabrielsen, Cen-
tre d’Etudes Nucle´aires de Saclay, Gif-sur-Yvette, cedex,
France. The cDNA encoding hCHD4 was obtained by
supplementing/modifying a hCHD4 cDNA sequence (kind
gift of Prof. M. Takahashi, Nagoya University, Japan)
with a DNA fragment from pCMV-SPORT6 hMi2b (cat.
no.: IRAT p970A0270D; ImaGenes Berlin, Germany). The
mammalian expression vectors encoding C-terminal GFP-
and RFP-tagged hCHD3/4 and the insect cell expres-
sion vectors encoding C-terminally Flag-tagged hCHD3/4
were created by recombining the respective entry clones
with pEGFP-N1 GWc (kind gift from Prof. G. Schotta;
Biomedical Center Munich-Molecular Biology; Ludwig-
Maximilians-University, Planegg-Martinsried, Germany),
pTagRFP-N DEST (in-house production) and pDFB6 C-
Flag (in-house production) according to the LR recombina-
tion reaction protocol (see above). The cDNA for GFP and
hCHD3/4-GFP were subcloned into pcDNA™5/FR/TO
which was purchased like pOG44 from Life Technologies.
The plasmid named pPCRScript slo1-gla75 encodes for a
dimeric nucleosome positioning sequence with rDNA and
hsp 70 DNA flanking sites (see below) and was purchased
from Sloning BioTechnology GmbH Puchheim, Germany.
The plasmid pUC18 12x-601 contains 12 copies of a nucleo-
some positioning sequence (in house production). The plas-
mids ‘pUC19 10 x -190/+90’ and ‘pUC19 7 x HSP70’ con-
tain 10 copies of the mouse rDNA promotor from bp –190
to + 90 in regard to the transcription start site and 7 copies
of the drosophila melongaster HSP70 promotor, respec-
tively (in-house production). The construct pBS 601-10N-
601 encoding a paired nucleosome positioning sequence
(NPS) sequence separated by 10 nucleotides was obtained
from Joseph C. Reese (44). The cDNAs for human H2A,
H2B, H3 and H4 were subcloned into pET21a (Novagen).
The constructs encoding RFP tagged HP1 alpha were de-
scribed in (45). All constructs were verified by sequencing.
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Reagents and antibodies
Gateway® BP Clonase® Enzyme Mix and Gateway®
LR Clonase® Enzyme mix (Life Technologies); anti
HDAC1 ab (Santa Cruz: SC-7872); anti MTA2 ab (Ab-
cam: ab8106); antiRbAp46 ab (Abcam: ab3535); anti Tubu-
lin ab [DM1A] (Abcam: ab7291); anti CHD3 ab and
anti CHD4N ab (Prof. Weidong Wang, National Insti-
tute on aging, Baltimore, Maryland, USA or (35)); anti
Mi-2 antibody H-242 (Santa-Cruz: sc-11378 X); anti HP-
1  ab (Merck Millipore: MAB3446); anti HP-1  ab
(Abcam: ab10478); anti HP-1  ab (Merck Millipore:
MAB3450); HRP anti rabbit (Jackson Immuno Research
Laboratories Inc.: 111-035-144) andHRPantimouse (Jack-
son Immuno Research Laboratories Inc.: 115-035-146);
mouse monoclonal anti rabbit IgG light chain HRP con-
jugated ab (Abcam ab 99697) and mouse monoclonal
anti rabbit IgG heavy chain HRP conjugated ab (Ab-
cam ab 99072); Alexa 594-anti rabbit (Molecular Probes:
A-11012); GFP-Trap® A Beads and Binding control-
agarose beads for preclearing (from Chromotek); ANTI-
FLAG® M2 Affinity Gel and FLAG® Peptide (Sigma
Aldrich); HiTrap SP FF and HiLoad 16/60 Superdex 200
(Amersham); Protein A-Sepharose GE CL-4B 17-0780-01
(Sigma Aldrich); Amicon Ultra Centrifugal Filter Unit
[MWCO 10 kDa] (Millipore); (protease free, fatty acid
free, essentially globulin free) BSA (Sigma Aldrich); gelatin
from cold water fish skin (Sigma Aldrich); NuPAGE®
Novex® 4–12% Bis-Tris Protein Gels, 1.0 mm, 10 well (Life
Technologies); NucleoSpin RNA Kit (Macherey-Nagel);
TruSeq RNA Sample Preparation Kit v2 (Illumina); iS-
cript™ cDNA Synthesis Kit (Bio-Rad); FCS [‘Tetracy-
cline free’] (Biochrom); FCS (Gibco); DMEM (1x) +
GlutaMAX™-I [1g/l glucose] (Life Technologies); Gibco
Sf-900™ II SFM (1×) Serum free Medium (Life Technolo-
gies); Doxycycline (Clontech Laboratories, Inc.); Zeozin
(Life Technologies), Hygromycin (Life Technologies), Blas-
ticidin (Life Technologies); FuGENE® HD transfection
reagent (Promega); Effectene transfection reagent (Qiagen);
HotStarTaq® Plus DNA Polymerase (Qiagen); SuperSig-
nal West Dura Extended Duration Substrate and SuperSig-
nal West Femto Trial Kit (Thermo Scientific); Triton X-100
(Sigma Aldrich); Igepal CA-630 (Sigma Aldrich); Tween-
20 (Roth); Hydroxylapatite, Fast Flow (Calbiochem); 2-
Mercaptoethanol (Merck); PEG4000 (Roth); TrypsinGold,
mass spectrometry grade (Promega); 32P- -ATP (Hart-
mann Analytic); Benzonase ≥ 250 U/l (E1014 Sigma-
Aldrich); Ethidium bromide (Roth).
Cell lines and strains
Cells of the human U2OS osteosarcoma cell line (HTB-96)
and U2OS cells, containing stably integrated lacO-repeats
(46), were cultured in DMEM/10% FCS (47). Flp-In™
T-REx™ 293 cells (Life technologies) were cultured at in
DMEM/10% tetracyclin free FCS/100 g/ml Zeozin/10
g/ml Blasticidin (before transfection). BL21(DE3) strain
was obtained from Novagen.
Preparation of chicken histones
All steps were carried out at 4◦C in the presence of pro-
teinase inhibitors. Red blood cells from 130 ml (adult)
chicken blood were pelleted by centrifugation at 3893g for
5 min. Afterward, the pellet (in total: 30 ml red blood
cells) was washed two times in the following buffer: 10
mM Tris pH 7.5/140 mM NaCl/15 mM NaCitrate. Fi-
nally the cells were lysed by resuspending them in 90 ml
of buffer A (15 mM Tris pH 7.5/15 mM NaCl/60 mM
KCl/340mMSucrose/1.5mM2-mercaptoethanol/0.5mM
spermidine/0.15 mM spermin), supplemented with 0.5%
Igepal CA-630. The cell lysate was immediately filtered
through 8 layers of cheese cloth (Stricker). The whole flow-
through was diluted 1:2 in buffer A and centrifuged for 10
min at and 3893g. To remove the remaining haemoglobin
from the nuclei-containing pellet, the latter was subse-
quently washed several times at in buffer A until the su-
pernatant became transparent. The pellet was finally resus-
pended in 10 ml buffer A and stored in 1–1.5 ml aliquots at
–80◦C. 1.5 ml of white coloured nuclei were finally lysed for
10min in 25ml of 50mM sodiumphosphate pH 6.8, supple-
mented with 480 mM NaCl and 1 mM 2-mercaptoethanol
under continuous stirring. The nuclear lysate was soni-
cated with a Branson sonifier (Emerson Electric Co) un-
til there were no (DNA) particles visible any longer. Af-
terwards 10 g hydroxylapatite and 50 ml 50 mM sodi-
umphosphate pH 6.8, supplemented with 480 mM NaCl
and 1 mM 2-mercaptoethanol were added under continu-
ous stirring. After pelleting the hydroxylapatite for 5 min
at 3893g, the latter was washed 3× in 50 mM sodiumphos-
phate pH 6.8, supplemented with 480 mMNaCl and 1 mM
2-mercaptoethanol and subsequently 5× in 50 mM sodi-
umphosphate pH 6.8, supplemented with 700 mM NaCl
and 1 mM 2-mercaptoethanol. The histones were eluted
by adding 50 mM sodiumphosphate pH 6.8, supplemented
with 2.5 M NaCl and 1 mM 2-mercaptoethanol (5 × 15
ml steps). Fractions were pooled, dialyzed (MWCO 6–8
kDa) against 20 mM Tris–HCl pH 7.6/2 M KCl/1.5 mM
MgCl2/0.5 mM EGTA/25% glycerol and concentrated via
PEG4000. The histone solution was analyzed via SDS gel
electrophoresis for stoichiometrically correct histone distri-
bution and quantified via absorptionmeasurement at A 230
nm (Abs of 4.3 corresponds to 1 mg/ml histones).
Preparation of human histones
Recombinant human histones were purified using an
adapted protocol from (48) and detailed protocol can be
obtained upon request. In brief, the expression of human
H2A, H2B, H3 and H4 in BL21(DE3) strains was induced
at OD 0.6 with 2 mM IPTG for 2–3 h at 37◦C. The pro-
teins were purified from inclusion bodies in 20 mM Tris–
HCl pH 7.5/10 mMDTT/7 M guanidinium hydrochloride
(buffer A) and dialyzed (MWCO 6–8 kDa) against 20 mM
NaAC pH 5.2/200 mM NaCl/1 mM Na-EDTA/5 mM 2-
mercaptoethanol/7 M urea. The denatured, single histones
were loaded on a HiTrap SP FF column and eluted by a
salt gradient (0.2–1 M). The eluted histones were dialyzed
against water, supplemented with 2 mM2-mercaptoethanol
(MWCO 6–8 kDa) and lyophilized with a Speed Vac Con-
centrator (Savant). For reconstituting histone octamers, sin-
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Table 1. Primers for generating nucleosomal DNA-templates
Forward primer (5′-3′): Reverse Primer (5′-3′): Symmetrically positioned mononucleosomes
atc ttt tga ggt ccg gtt ctt t gta cag aga ggg aga gtc aca aaa c 77-NPS-77
atg ttt ggg cc acct ccc c taa cgg cct taa gag aaa ttt ct 40-NPS-40
gat cca gaa tcc tgg tgc tga g tag ctg tat ata tct gac aca tg 0-NPS-0
Forward primer (5′-3′): Reverse Primer (5′-3′): Asymmetrically positioned mononucleosomes
gat cca gaa tcc tgg tgc tga g gta cag aga ggg aga gtc aca aaa c 0-NPS-77
ggccgccctggagaatc Cy3-gcgtatagggtccatcacataacc 6-NPS-47 (pUC18 12x-601) assembly with human octamers
Forward primer (5′-3′): Reverse Primer (5′-3′): Dinucleosome
gcgaattggagctccaccgc ggaattcctgcagaccgggg 601-10N-601
gle histones in buffer A were mixed at equimolar amounts,
followed by a renaturing step (dialysis) in 10 mM Tris–HCl
pH 7.5/1 mM Na-EDTA/5 mM 2-mercaptoethanol/2 M
NaCl (buffer B). The reconstituted octamers were separated
from dimers and high molecular weight aggregates by a
gel filtration step with a HiLoad 16/60 Superdex 200 col-
umn. The protein concentration was adjusted to 1mg/ml in
buffer B with Amicon Ultra Centrifugal Filter Units. After-
wards, octamers were analyzed via SDS gel electrophoresis
for stoichiometrically correct histone distribution and sup-
plemented with an equal volume of 100% glycerol.
Nucleosome assembly
For the assembly of symmetric and asymmetric mononu-
cleosomes, the plasmids pPCRScript slo1-gla75 (i) and
pUC18 12x-601 (ii) were digested with Bgl II (i) and NotI
(ii). The released fragments were purified via gel extraction
and served as a PCR template to generate the diverse as-
sembly templates (Table 1).
agatcttttgaggtccggttcttttcgttatggggtcatatgtttgggccacctcc
ccatggtatgacttccaggtatggatccagaatcctggtgctgaggctgctcaatt
ggttgtagcaagctctagcactgcttaaatgcatgtacgcgcggtcccctgtgttt
taactgccaaggggattactccctagtctccaggcatgtgtcagatatatacag
ctagctacaaagaaaactcgagaaatttctcttaaggccgttattctctagattcg
ttttgtgactctccctctctgtactaagatct (pPCRScript slo1-gla75;
sequence between two BglII sites: 310 bp)
gcggccgccctggagaatcccggtgccgaggccgctcaattggtcgtagcaa
gctctagcaccgcttaaacgcacgtacgcgctgtcccccgcgttttaaccgcca
aggggattactccctagtctccaggcacgtgtcagatatatacatcctgtgcatgt
attgaacagcgactcgggttatgtgatggaccctatacgcggccgc (pUC18
12x-601; sequence between two NotI sites: 208 bp)
For the assembly of the mouse rDNA promotor and the
drosophila HSP70 promotor mononucleosomes the plas-
mids ‘pUC19 10x -190/+90’ (i) and ‘pUC19 7x HSP70’ (ii)
were digested with AvaI (i) and EcoRI (ii). The restriction
digest reactions with the released fragments were used as a
template for the assembly procedure (see below).
cccgggtatcagttctccgggttgtcaggtcgaccagttgttcctttgaggtcc
ggttcttttcgttatggggtcatttttgggccacctccccaggtatgacttccagg
tattctctgtggcctgtcactttcctccctgtctcttttatgcttgtgatcttttctatc
tgttcctattggacctggagataggtactgacacgctgtcctttccctattaacac
taaaggacactataaagagaccctttcgatttaaggctgttttgcttgtccagcct
attcccggg (pUC19 10x -190/+90 mouse rDNA promotor;
sequence between two AvaI-sites: 291 bp)
gaattcggatcccacgataagcataaccaagctctgcgattatctctaccataa
ttaatttaagcagccgtatttataaagaaatttccaaaataaagcgaatattctag
aatcccaaaacaaactggttgttgcggtaggtcatttgtttggcagaaagaaaa
ctcgagaaatttctctggccgttattctctattcgttttgtgactctccctctctgta
ctattgctctctcactctgtcgcacagtaaacggcacactgttctcgttgcttcga
gagagcgcgcctcgaatgttcgcgaaaagagcgccggagtataaatagaggc
gcttcgtcgacggaacgtcaattcagatctgaattc (pUC19 7x HSP70
drosophila HSP70 promotor; sequence between two EcoRI
sites: 366 bp)
For the assembly of the dinucleosomes, the sequence be-
low was amplified via PCR (Table 1) from the plasmid pBS
601-10N-601:
gcgaattggagctccaccgcggtggcggccggccgccctggagaatcccggt
gccgaggccgctcaattggtcgtagacagctctagcaccgcttaaacgcacgta
cgcgctgtcccccgcgttttaaccgccaaggggattactccctagtctccaggcac
gtgtcagatatatacatcctgtgccgctctagaagccctggagaatcccggtgccg
aggccgctcaattggtcgtagacagctctagcaccgcttaaacgcacgtacgcg
ctgtcccccgcgttttaaccgccaaggggattactccctagtctccaggcacgtgt
cagatatatacatcctgtgccgctctagaagtattgtattccccggtctgcaggaa
ttcc (pBS 601-10N-601; 388 bp)
The nucleosome assembly was performed via salt gradi-
ent dialysis. Briefly, an assembly reaction (50–200 l) con-
tained chicken/human octamers and DNA (both in the
g range) in ratios of 0.6–1.6: 1 (histones: DNA) in high
salt buffer (10 mM Tris pH 7.6/2M NaCl/1 mM EDTA/1
mM 2-mercaptoethanol/0.04–0.05% Igepal CA-630), sup-
plemented with 200 ng/l BSA. The reaction was pipet-
ted into a 1.5 ml Protein LoBind tube (Eppendorf) which
was placed head first in a foam-floater in 300 ml high salt
buffer. The tubes were manipulated in advance by introduc-
ing a hole of 6 mm diameter into the lid and by removing
the bottom. Subsequently, a 1 cm2 piece of a buffer equili-
brated dialysis membrane (MWCO 6–8 kDa) was mounted
between lid and tube. After removing air bubbles between
dialysis membrane and buffer, 3 L of low salt buffer (10
mM Tris pH 7.6/50 mM NaCl/1 mM EDTA/1 mM 2-
mercaptoethanol/0.05% Igepal CA-630) were pumped with
a flow rate of 200 ml/h into the beaker containing the
dialysis reaction. The success of an assembly reaction was
checked by loading 200–500 ng of the nucleosomes (concen-
tration determined via the applied DNA amount per reac-
tion) on a PAA-gel, using non-assembledDNAas a control.
Nucleosome remodeling assay
A nucleosome remodeling assay was performed in 20 mM
Tris pH 7.6/80–120 mM KCl/1.5 mM MgCl2/0.5 mM
EGTA/10% glycerol/1–1.8 mM ATP (in case of the din-
ucleosome reaction extra BSA was added to reach a fi-
nal concentration of 90 ng/l) at 26◦C/30◦C for 30–80
min (10–11 l reaction volume in total). Nucleosomes were
added in concentrations ranging from 130 to 300 nM (77-
NPS-77; 40-NPS-40; 0-NPS-0; 0-NPS-77 and 6-NPS-47) or
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13.6–44 ng/l (601-10N-601; drosophila HSP70 promotor
and –190/+90 mouse rDNA promotor) respectively. The fi-
nal concentration of recombinant nucleosome remodeling
enzymes varied from 25 to 400 nM. The enzymatic reac-
tionswere stopped by adding 300–1000 ng competitor (plas-
mid) DNA for 5 min (at 30◦C or on ice). The nucleosome
movements were visualized by supplementing the reactions
with glycerol (4–5%) and loading them on 5–6% PAA gels,
which were subsequently scanned on a Fluorescence Image
Reader FLA-5000 (Fujifilm) or stained with ethidium bro-
mide.
ATPase assay
Recombinantly purified CHD3-FLAG or CHD4-FLAG
(both 40 nM) were incubated with 130 nM mononucleo-
somes (77-NPS-77) in 20 mM Tris–HCl pH 7.6/120 mM
KCl/1.5 mM Mg2+/0.5 mM EGTA/10% glycerol in the
presence of 500MATP and 0.2Ci 32P- -ATP for 40min
at 30◦C.Released 32P- phosphate was separated from non-
hydrolyzed 32P- -ATP by TLC on PEI-Cellulose F plates
(Merck) [mobile phase: 50% acetic acid, 0.5 mMLiCl]. 32P-
 and 32P- -ATP ratioswere calculated after phosphoimag-
ing (Fuji Film FLA-3000), using Fuji Multi Gauge Soft-
ware and Excel. Concentration of hydrolyzed ATP was cal-
culated from these ratios and the (total) initial ATP con-
centration in the assay. Averages and standard deviations
for the ATPase rates represent three experiments, done with
two to three independent protein preparations.
Purifying recombinant hCHD3/4 from insect cells
V1 virus encoding for C-Flag hCHD3/4 were created ac-
cording to (49). Briefly, pDFB6 C-Flag with hCHD3/4
was transformed into chemically competent DH10Bac EM
YFP (kind gift from Dr. Imre Berger, EMBL Grenoble,
Grenoble Cedex 9, France) (49,50), whereby positive trans-
formants were screened via blue-white screening. Several
clones were used to isolate the bacmid DNA (created via
Tn7 transposition) by alkaline lysis. The isolated DNA was
transfected afterwards into Spodoptera frugiperda (Sf21)
cells using Fugene HD. The initial virus (V0) was collected
from YFP positive cells and used for producing the gener-
ation 1 virus (V1), which was in turn used for performing
large scale infections. Forty-eight hours after V1-infected
Sf21 cells stopped dividing (day of proliferation arrest), cells
were harvested by centrifugation (10 min/RT/800g). For
purifying recombinant C-Flag hCHD3 or CHD4, 80–120
× 106 cells were lysed in 20 mM Tris–HCl pH 7.6/500 mM
KCl/1.5 mM MgCl2/0.5 mM EGTA/10% glycerol/0.1%
Igepal CA-630 (30 ml), accompanied by three cycles of
freezing and thawing in liquid nitrogen. The thawed cell ex-
tract was sonicated using a Branson Sonifier 250 (Emerson
Electric Co.), followed by a 20 min centrifugation step at
4◦C (18 000g). The supernatant, containing the Flag-tagged
proteins, was incubated with 250 l ANTI-FLAG® M2
Affinity Gel (gravity flowmethod). After washing the beads
with lysis buffer and 20 mM Tris–HCl pH 7.6/300 mM
KCl/1.5 mM MgCl2/0.5 mM EGTA/10% glycerol/0.1%
Igepal CA-630, the protein was eluted in 20 mM Tris–HCl
pH 7.6/300 mMKCl/1.5 mMMgCl2/0.5 mMEGTA/10%
glycerol/0.1% Igepal CA-630 containing 500 ng/l and
FLAG® Peptide (5 × 250 l elution steps). The protein
concentration was estimated via Bradford assay and the pu-
rity was checked with Coomassie-stained SDS gels. The ac-
tivity of the respective enzyme fractions was tested by nu-
cleosome remodeling assays (see above).
Stable cell lines
Before transfection, Flp-In™ T-REx™ 293 cells (Life tech-
nologies) were cultured in DMEM/10% tetracyclin free
FCS/100 g/ml Zeozin/10 g/ml Blasticidin. The cells
were transfected with the pOG44 plasmid and the respec-
tive pcDNA 5/FRT/TO constructs encoding CHD3-GFP,
CHD4-GFP or GFP (see above), using Fugene HD ac-
cording to the Fugene and TRex Flp-In system manu-
als. Twenty-four hours after transfection, the selection pro-
cess was started by incubating the cells with DMEM/10%
tetracycline free FCS/100 g/ml Hygromycin/10 g/ml
Blasticidin. After 10–14 days several individually visible
colonies were selected and screened for reliable induction
after adding 1 ng/l doxycycline via western blot and fluo-
rescence microscopy.
Preparation of whole cell extract (WCE)
Flp-In™ T-REx™ 293 cells with GFP, CHD3-GFP and
CHD4-GFP were induced with 1 ng/l doxycycline at
∼70% confluency for 24 h. Cells from two 150 mm (ø) cul-
ture dishes were lysed in 20 mM Tris–HCl pH 7.6/1.5 mM
MgCl2/0.5 mM EGTA/150 mM KCl/10% glycerol/1 mM
DTT/1.0% IGEPAL CA-630. Protein concentrations were
determined by Bradford assay.
Preparation of nuclear extract (NE)
For preparation of nuclear extract, Flp-In™ T-REx™ 293
cells or stably transfected Flp-In™ T-REx™ 293 cells with
GFP, CHD3-GFP and CHD4-GFP were used. The stably
transfected cells were induced with 1 ng/l Doxycycline
at ∼70% confluency for 24 h. Cells from four 150 mm (ø)
culture dishes were lysed in 4 ml buffer A (10 mM Tris–
HCl pH 7.6/3 mM MgCl2/10 mM NaCl/0.5% IGEPAL
CA-630) by vortexing. The cell extract was centrifuged (10
min, 4◦C, 500g) and the nuclei-pellet was washed twice
with buffer A. The nuclei were finally lysed on a vortex by
adding 800 l buffer B (15 mM Tris–HCl pH 7.6/60 mM
KCl/500 mM NaCl). The released DNA was pelleted by
ultra-centrifugation (120 000g, 10 min, 4◦C, rotor: Beck-
man Coulter TLA100.4, Beckman Coulter Optima TL Ul-
tracentrifuge 100 000 rpm). The supernatant (nuclear ex-
tract) was quantified via Bradford assay.
Co-IP experiments
Co-IP experiments were performed with either 5 mg whole
cell extract (WCE) or 1 mg nuclear extract (NE) in IP buffer
(20 mM Tris–HCl pH 7.6/1.5 mM MgCl2/150 mM KCl
for WCE and 150 mM NaCl for NE/0.5 mM EGTA/10%
glycerol/1 mM DTT/0.25% IGEPAL CA-630) in a total
volume of 800l. For IPwithGFP-TrapA beads the lysates
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were precleared in advance in IP buffer for 1 h at 4◦C us-
ing 20 l Chromotek BAB-20 agarose beads. Lysates for IP
with Protein A beads (+ anti Mi-2 antibody and no anti-
body for negative control) were not precleared. Both, GFP-
Trap A beads and Protein A beads were preincubated for
1 hour at 4◦C in buffer A (20 mM Tris–HCl pH 7.6/1.5
mM MgCl2/150 mM KCl for WCE and 150 mM NaCl
for NE/0.5 mM EGTA/10% glycerol/1 mM DTT) supple-
mented with 1% gelatin and 200 ng/l BSA. In case of mass
spectrometry experiments the GFP-Trap A beads were not
blocked. ForGFP-IP experiments, the precleared lysate was
incubated for 3–4 h with GFP-Trap A beads on a rotating
wheel at 4◦C. For Mi-2-IP reactions, the lysate was incu-
bated in the presence or absence of ≥ 125 U Benzonase or
200 ng/l Ethidium bromide with 5 gMi-2 antibody for 2
h on a rotating wheel at 4◦C, whereby after two hours 20
l blocked protein A beads were added for a further in-
cubation time of 2 h. After the Co-IP reaction, all super-
natants were collected by centrifugation (2700g) and the
beads were washed four times in buffer A. For mass spec-
trometry, beads from Co-IP experiments were washed once
in buffer A (see above), once in buffer A with 500 mM KCl
(see above), followed by two further washing steps in buffer
A (see above). For Mi-2-IP reactions, beads were washed
once in buffer A, 3× in buffer Awith 500mMKCl and once
more with buffer A. All beads were finally resuspended in
2× Laemmli buffer and boiled for 5 min at 80◦C. 5–25%
of one IP reaction and 15 g of the input and supernatant
fraction were used for the western blot or mass spectrome-
try analyses.
Western blot
After semi dry western blotting, the PVDFmembrane (Mil-
lipore) was blocked over night at 4◦C in 5% milk powder
in PBS with 0.2% Tween. Primary antibodies were diluted
1:1000 or 1:2000 in blocking solution (see above) and in-
cubated for 1 h at RT. Afterwards, the membranes were
washed five times for 5 min in PBS with 0.2% Tween. HRP-
coupled secondary antibodies were diluted 1:5000 in block-
ing solution (see above) and incubated for 1 h at RT. The
membranes were washed again five times (see above) and
incubated with the SuperSignalWest Dura ExtendedDura-
tion Substrate or SuperSignalWest Femto Trial Kit accord-
ing to themanufacturers protocol. Images were recorded on
a FujiFilm LAS-3000 image reader (FujifilmHoldings Cor-
poration).
Mass spectrometry
25% of one Co-IP reaction were loaded on a NuPAGE®
Novex® 4–12% Bis-Tris Protein Gels, 1.0 mm, 10 well.
The gels were run in 1 x MOPS buffer according to
the manufacturer’s protocol. For mass spectrometric anal-
ysis of proteins, a gel lane was cut into 12 consecu-
tive slices. The gel slices were then transferred into 2
ml micro tubes (Eppendorf) and washed with 50 mM
NH4HCO3, 50 mM NH4HCO3/acetonitrile (3/1) and 50
mM NH4HCO3/acetonitrile (1/1) while shaking gently in
an orbital shaker (VXR basic Vibrax, IKA). Gel pieces
were lyophilized after shrinking by 100% acetonitrile. To
block cysteines, reduction with DTT was carried out for
30 min at 57◦C followed by an alkylation step with iodoac-
etamide for 30 min at room temperature in the dark. Sub-
sequently, gel slices were washed and lyophilized again as
described above. Proteins were subjected to in gel tryptic
digest overnight at 37◦C with approximately 2 g trypsin
per 100 l gel volume. Peptides were eluted twice with
100 mM NH4HCO3 followed by an additional extraction
with 50 mM NH4HCO3 in 50% acetonitrile. Prior to LC–
MS/MSanalysis, combined eluates were lyophilized and re-
constituted in 20 l of 1% formic acid. Separation of pep-
tides by reversed-phase chromatography was carried out
on an UltiMate 3000 RSLCnano System (Thermo Scien-
tific, Dreieich), which was equipped with a C18 Acclaim
Pepmap100 preconcentration column (100m i.D.x20mm,
Thermo Fisher) in front of an Acclaim Pepmap100 C18
nano column (75m i.d.× 150mm, Thermo Fisher). A lin-
ear gradient of 4% to 40% acetonitrile in 0.1% formic acid
over 90 min was used to separate peptides at a flow rate of
300 nl/min. The LC-system was coupled on-line to a maXis
plus UHR-QTOF System (Bruker Daltonics, Bremen) via
a CaptiveSpray nanoflow electrospray source (Bruker Dal-
tonics). Data-dependent acquisition of MS/MS spectra by
CID fragmentation was performed at a resolution of min-
imum 60 000 for MS and MS/MS scans. The MS spectra
rate of the precursor scan was 2 Hz processing a mass range
between m/z 175 and m/z 2000. Via the Compass 1.7 ac-
quisition and processing software (Bruker Daltonics) a dy-
namic method with a fixed cycle time of 3 s and a m/z de-
pendent collision energy adjustment between 34 and 55 eV
was applied. Raw data processing was performed in Data
Analysis 4.2 (Bruker Daltonics), and Protein Scape 3.1.3
(Bruker Daltonics) in connection with Mascot 2.5.1 (Ma-
trix Science) facilitated database searching of the Swiss-Prot
Homo sapiens database (release November 2015, 20 194 en-
tries). Search parameters were as follows: enzyme specificity
trypsin with two missed cleavages allowed, precursor toler-
ance 0.02Da,MS/MS tolerance 0.04Da, carbamidomethy-
lation or propionamide modification of cysteine, oxidation
of methionine, deamidation of asparagine and glutamine
were set as variablemodifications.Mascot peptide ion-score
cut-off was set 25. Protein list compilation was done using
the Protein Extractor function of Protein Scape. Further-
more, we considered protein identification as confident, if
the following criteria were met: at least two unique peptides
found and a minimum protein score of 100. If necessary,
fragment spectra were validated manually.
Fluorescence microscopy and colocalization analysis
Images of induced and non-induced Flp-In™ T-REx™
293 cells with CHD3-GFP, CHD4-GFP and GFP were
recorded using an Axiovert 200M (Carl Zeiss AG) micro-
scope and the Axiovision Rel. 4.7 software (Carl Zeiss AG).
Briefly, cells were fixed, washed 3× with PBS, stained with
DAPI (see above), washed again 3× with PBS and directly
mounted in 50% glycerol/PBS (see above).
Live cell imaging of U2OS cells expressing different com-
binations of GFP/RFP-tagged proteins was conducted at a
Leica SP5 confocalmicroscope as previously described (45).
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Colocalization of CHD3-GFP and CHD4-RFP was as-
sessed using the Pearson correlation coefficient (51) and
the intensity correlation coefficient (ICQ) (52) as described.
First, the background intensity IBG in a region outside
of the cell nucleus and the average intensity IAVG within
the cell nucleus were determined for each colour chan-
nel. Next, normalized intensity values were calculated
according to Inorm = (I - IBG)/(IAVG - IBG). Based on
these normalized intensities, the Pearson correlation co-
efficient was calculated according to r = Cov(Inorm,red,
Inorm,green)/SD(Inorm,red)/SD(Inorm,green), where Cov and SD
denote the covariance and the standard deviation, respec-
tively. The slope m and the y-intercept c of the regres-
sion line were obtained according to m = Cov(Inorm,red,
Inorm,green)/SD(Inorm,green)2 and c= 1 –m. Covariation plots,
ICQ values and psign test values were calculated as previously
described (52).
Fluorescent three-hybrid (F3H) assay
F3H assays were conducted as described previously (53). In
brief, U2OS cells containing stably integrated lacO arrays
were plated on coverslips in DMEM supplemented with
10% FCS. On the next day, cells were transfected with plas-
mids encoding a bacterial LacI repressor fused to GFP-
binding protein (LacI-GBP), a GFP-tagged bait protein
(GFP-, CHD3-GFP or CHD4-GFP), and optionally an
RFP-tagged prey protein (CHD3-RFP or CHD4-RFP) us-
ing Effectene. After 24 h, live cells were either imaged by
confocal microscopy, or cells were fixed for 10 min in 4%
paraformaldehyde/PBS and washed 3× with PBS. Next,
the cells were permeabilised with 0.25% Triton X-100/PBS
for 25 min at RT and washed 3× in PBS. Afterward, the
cells were blocked in 2% BSA/PBS for 1 h. Primary an-
tibodies were diluted 1:200 or 1:1000 in blocking solution
(see above) and incubated for 1 h at RT. The cells were
washed again 3× with PBS and incubated for 1 h at RT
with an Alexa-594 labeled secondary antibody which was
diluted 1:500 in blocking solution (see above). Finally the
cells were washed 3× with PBS and stained for 2 min with
DAPI (50 ng/l)/PBS. After this step, the cells were washed
3× in PBS and mounted on microscopy slides with 50%
glycerol/PBS.
Images for the PFA-fixed cells were acquired using a
Leica SP8 confocal microscope with the Leica LAS AF
V4.0 software. The following excitation and emission wave-
lengths were used: DAPI (405 nm/415–480 nm), GFP (488
nm/500–550 nm) and Alexa-594 (561 nm/570–680 nm).
Images were evaluated using the Leica LAS AF V4.0 soft-
ware and ImageJ 1.49s. The lacO sites in the nucleus recruit-
ing GFP, CHD3-GFP and CHD4-GFP were evaluated as
colocalized with the protein of interest, if the Alexa-594 sig-
nal at the lacO site was at least 1.7-fold higher than in the
rest of the nucleus.
Fluorescence cross-correlation spectroscopy (FCCS)
For FCCS experiments, U2OS cells were transfected with
different combinations of GFP/RFP-tagged proteins as in-
dicated using Effectene. On the next day, measurements
were conducted for 60 seconds using a Zeiss LSM 710 mi-
croscope equippedwith a 63×/NA1.2 water immersion ob-
jective and a Confocor3 unit. GFP and RFP were excited
with a 488 nm Argon laser line and a 561 nm DPSS laser
line, respectively. Emitted signals were recorded through a
BP 505–540 IR filter and a LP 580 filter. Data were anal-
ysed as described previously (45). In brief, auto- and cross-
correlation functions were computed using the self-written
STC- or software. After removal of spectral cross talk,
functions were fitted to an anomalous diffusion model to
quantify themobility of GFP/RFP-tagged proteins and the
abundance of double-labeled complexes containing at least
one GFP-tagged and one RFP-tagged protein.
Laser microirradiation
Laser microirradiation experiments were conducted as pre-
viously described (54). In brief, U2OS cells expressing
HP1-RFP andCHD3-GFPorCHD4-GFPweremounted
on a Leica SP5 confocal microscope and imaged using a
63× oil immersion objective. Subsequently, a circular region
of interest with a diameter of 1 m was selected and irradi-
ated with a 405 nm diode laser at a power of 1.5 mW in the
back aperture of the objective. For irradiation, the region
was scanned 16-times, corresponding to a net exposure time
of∼0.1 ms for each pixel or∼1.5 s for the entire region. Af-
ter irradiation, image series in the GFP and RFP channel
were acquired and the enrichment of the different proteins
over time was quantified.
RNA isolation, transcription to cDNA, library preparation
and sequencing
Total RNA was prepared from 24 h induced (1 ng/l Dox)
and non-induced Flp-In™ T-REx™ 293 cells (2 million cells
per sample were seeded one day before induction). For har-
vesting the cells, they were scraped from the culture dishes
and pelleted at 1600 g and 4◦C for 10 min. The RNA iso-
lation procedure was performed with the NucleoSpin RNA
Kit according to the manufacturer’s instructions. Five in-
dependent induction series served as RNA sources for the
RNA-seq and qPCR experiments, presented in this study.
The (i) sequencing and (ii) qPCR experiments were both
performed with (i) two and (ii) three complete sets of total
RNA preparations, respectively.
Reverse transcription of 1 g total RNA (quantified with
a NanoDrop 1000 Spectrophotometer [Thermo Scientific]
Nucleic Acids-RNA-40 measurement mode) into cDNA
(for qPCR), using oligo(dT) and random hexamer primers,
was performed with the iScript™ cDNA Synthesis Kit ac-
cording to the manufacturer’s protocol.
Library preparation, comprising rRNA depletion, polyA
enrichment, fragmentation to ∼270 nucleotide length and
reverse transcription to cDNA, using random hexamer
primers and adapter ligation, was accomplished with the
TruSeq RNA Sample Preparation Kit v2 according to the
manufacturer’s protocol by EMBL GeneCore facility in
Heidelberg (Dr. Vladimir Benes). Libraries were sequenced
on Illumina HiSeq2000 platform resulting in 37–71 Mio 50
bp paired-end reads per sample.
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Table 2. Primers for quantitative PCR (qPCR)
Gene-/ Primer-name Sequence in 5′-3′- orientation
hZNF467 1fw agctccctgggattctctgt
hZNF467 1re catctgctcctgggcattat
hRGS19 5fw cgaggctcatctacgaggac
hRGS19 5re ggctcctgcatcttcttgtt
hUSE1 2fw ggacaaccagaccctgtcac
hUSE1 2re gacgctctgactccgtcttc
hSumo3 6fw ggcagccaatcaatgaaact
hSumo3 6re aacacgtcgatggtgtcctc
hLaminA/C fw tgcgtacggctctcatcaact
hLaminA/C re ctcgtcgtcctcaaccacagt
RNA-seq analysis
Raw reads were mapped to the UCSC human genome ver-
sion 37 (hg19) gene annotation using TopHat2 (55) with
following parameters: -g 1 -N 1 - -no-novel-juncs - -realign-
edit-dist 2. Mapped reads were further analyzed in the
R environment (56) using Rsamtools, GenomicFeatures
and GenomicAlignments Bioconductor packages (57,58).
Mapped reads were counted over the transcript model us-
ing the union mode. Statistical analysis of differentially ex-
pressed genes was performed with the DESeq2 Bioconduc-
tor package (59). Samples without doxycycline induction
(uninduced) were considered as ground state and differen-
tial expression was determined as a statistical significant
(FDR < 0.1) change in expression over the ground state.
Coding DNA sequences of CHD3 (RefSeq-ID:
NM 001005271) and CHD4 (RefSeq-ID: NM 001273)
were obtained from the Ensembl data base (De-
cember 2013 release) using the biomaRt package
(60,61). The GFP-Sequence corresponds to the GFP-
sequence in pEGFP-N1 (Clontech) and is available at:
https://www.addgene.org/vector-database/2491 or upon
request. RNA-seq reads were mapped to the cDNA se-
quences using bowtie2 (62) with following parameters: -a
- -very-sensitive - -no-unal - -no-mixed - -no-discordant.
Properly aligned reads of each construct were counted
and normalized by the size factors obtained from DESeq
analysis (see above) and the length of the constructs.
Quantitative PCR (qPCR) and data analysis
Primers for quantitative PCR were designed with
Primer3web version 4.0.0 (free software). The quality
of the designed primer pairs was checked with PerlPrimer
(free) software v1.1.21 [http://perlprimer.sourceforge.net]
and by aligning them to the human genome and transcrip-
tome [Human genomic plus transcript (Human G + T)]
using nucleotide blast (blastn) feature from NCBI. The
primers were ordered from Sigma Aldrich (desalted) and
are listed in Table 2.
A qPCR reaction (
∑
20 l) contained 0.4 M of the re-
spective forward and reverse primers and 0.2 l of cDNA
(10 ng of total RNA). The PCR buffer was a 1:10 dilution
of 10× PCR buffer (Qiagen) supplemented with 0.2 mM
dNTPs (each) and 1 mM MgCl2 (both from Qiagen). The
final reaction comprised furthermore a 1:32.000.000 dilu-
tion of a 10.000× Sybr green I stock (Roche) and 0.4 U of
HotStarTaq® Plus DNA Polymerase.
Datawere collectedwith aRotor-Gene 3000 system (Cor-
bett Research/Qiagen) and analyzed using the comparative
analysis software module. All samples were run in triplicate
and Lamin A/C (Table 2) was used for normalization. The
mean values and error bars (calculated in Excel) are derived
from three biological replicates (with at least two technical
replicates for each biological replicate). Relative expression
values for induced (+dox) and non-induced (–dox) condi-
tions were tested for significance using a two tailed, ho-
moscedastic t-test inMicrosoft Excel.P-values are given for
sets with significant changes (*P < 0.05, **P < 0.01, ***P
< 0.001).
RESULTS
CHD3 and CHD4 form isoform-specific NuRD complexes
The twoMi-2 subfamilymembersCHD3andCHD4are co-
expressed in many cell lines and tissues and show an over-
all identity of 71.6% (Figure 1A and Supplementary Fig-
ures S1 and S2). The high similarity between both proteins
impedes the development of molecular biological and bio-
chemical tools for the detection and functional character-
ization of the respective CHD-isoform. In order to exam-
ine whether CHD3 and CHD4 coexist in the same NuRD
complex or if they form isoform-specific NuRD complexes,
we generated a doxycycline inducibleHek293-based cell line
(Flp-In™ T-REx™ 293) expressing either human CHD3 or
CHD4 with a C-terminal GFP tag, or GFP alone (Sup-
plementary Figure S3). The exogenously expressed proteins
were immunoprecipitated, using GFP-Trap® A beads and
the precipitation reactions were consequently analysed via
western blot and mass spectrometry (Figure 1B, C and
Supplementary Figures S4 and S5D). As expected, we ob-
served several core factors like HDAC1, RBBP7 (RbAp46)
andMTA2 specifically coprecipitating with both CHDpro-
teins by western blot and mass spectrometry analyses (Fig-
ure 1B,C and Supplementary Figure S4). We further de-
tected reported core factors like MTA1/3, p66 (alpha and
beta), RBBP4 (RbAp48) and MBD2/3 via mass spectrom-
etry (Figure 1C and Supplementary Figure S4), suggesting
that the GFP epitope did not interfere with proper forma-
tion of the NuRD complex. To analyse the precipitation re-
actions with respect to endogenous CHD proteins, we used
antibodies directed against humanCHD3 and CHD4 (Sup-
plementaryFigure S5B). Both antibodies exhibit weak cross
reactivity towards the other Mi-2 isoform, most probably
due to the above-mentioned high degree of similarity be-
tween both isoforms (Figure 1A and Supplementary Fig-
ures S1 and S5B). We therefore propose that the band ob-
tained with the CHD3 antibody in lane 3 of Figure 1B (
= CHD4-GFP IP reaction) corresponds to the precipitated
CHD4-GFP protein (Figure 1B, CHD3 blot, lane 3 with
black asterisk and Supplementary Figure S5). Similarly, the
antibody signal in lane 2 of Supplementary Figure S5D ( =
CHD3-GFP IP reaction) of the CHD4 western blot likely
represents the bait protein CHD3-GFP, which is recognized
by the antibody against CHD4 (Figure 1B and Supplemen-
tary Figure S5A-C and CHD4 blot, lane 2 with black cross
in Supplementary Figure S5D). Mass spectrometry analy-
ses from whole cell extract and nuclear extract IP experi-
ments did not reveal any significant enrichment of unique
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Figure 1. The highly similar CHD3 and CHD4 proteins form isoform specific NuRD complexes in living cells. (A) Upper panel: Schematic representation
for human CHD3 (UniProt Q12873) and CHD4 (UniProt Q14839) with the annotated functional domains like the paired PHD domains 1 and 2 (light
and dark blue), the paired Chromodomains 1 and 2 (light and dark rose) and the Helicase 1 (ATP binding) and the Helicase 2 domain (C-terminal) (light
and dark green). The unique C-terminal domain of CHD3 is presented in violet (see also (11)). Lower panel: Sequence alignement for CHD3 and 4 by
Clustal  (120). Identical amino acids were assigned a value of 1, groups of strongly similar amino acids were assigned a value of 0.66 and weakly similar
amino acids a value of 0.33. Mismatches were scored with a value of 0. The ‘shared cores’ of the annotated domains are highlighted in the same colors like
in the upper panel, below the diagram. CHD3 and CHD4 share an overall identity of 71.6%. (B) The expression of GFP (control), CHD3-GFP or CHD4-
GFP in stably transfected Flp-In™ T-Rex™ 293 cells was induced by doxycycline treatment for 24 hours. Subsequently, whole cell extract was prepared
and subjected to IP reactions, using GFP-Trap® A beads. The IP reactions were analysed by western blot with the indicated antibodies (black asterisk
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CHD3 or CHD4 peptides in the reaction of the respective
other isoform (Figure 1C and Supplementary Figure S4).
Our IP experiments therefore suggest that the twoCHD iso-
forms do not coexist in the same NuRD complex.
To validate this finding in the context of living cells we
used two microscopy-based approaches, namely the flu-
orescent three-hybrid (F3H) assay and fluorescence cross
correlation spectroscopy (FCCS). For F3H assays (53),
U2OS cells containing stably integrated lacO repeats (46)
were transfected with LacI-GBP (GFP-binding protein),
CHD3-GFP and CHD4-RFP (or CHD3-RFP and CHD4-
GFP), which resulted in recruitment of the GFP-tagged
protein to the lacO sites (Figure 1D). Even though im-
mobilized CHD3/4-GFP proteins were able to associate
with endogenous NuRD factors like HDAC1, RbAp46
and MTA2 (Supplementary Figure S6A,C), suggesting the
assembly/recruitment of NuRD complexes at the lacO ar-
rays, we did not observe any colocalization of RFP-tagged
CHD3 or CHD4 with the opposite or identical GFP-
tagged CHD isoform (Figure 1D and Supplementary Fig-
ure S6B,C). Next, we used FCCS to test if there are mo-
bile NuRD complexes containing both CHD isoforms (Fig-
ure 1E). Due to its high time resolution, FCCS can also
detect short-lived complexes that diffuse through the ob-
servation volume within a few milliseconds. Autocorrela-
tion functions show that a considerable fraction of CHD3-
GFP/RFP and CHD4-GFP/RFP is mobile (red/green
curves in Figure 1E, bottom and Supplementary Fig-
ure S6D). Based on the small amplitudes of the cross-
correlation curves obtained for CHD3-GFP/CHD4-RFP
and CHD3-RFP/CHD4-GFP (black curves in Figure 1E,
bottom), we conclude that these mobile CHD3/4molecules
are not in complex with a labelled member of the other iso-
form. Furthermore, these molecules are neither in complex
with another labelled member of the same isoform (black
curves in Supplementary Figure S6D).
These data strongly suggest that cells contain isoform-
specific NuRD complexes, which use either CHD3 or
CHD4 as the motor subunit. In contrast to remodeling en-
zymes such as human Snf2h/Acf (47), the human CHD
proteins do not tend to form homomers. Since many cell
lines and tissues coexpress CHD3 and CHD4 (Supplemen-
tary Figure S2), which share moreover many core subunits
like HDAC1/2, MTA2/3 or RBBP4/7 (and others) (Fig-
ure 1B,C and Supplementary Figure S4), this observation
raises the question about the physiological relevance of the
coexistence of such structurally similar NuRD complexes:
DoCHD3 andCHD4-NuRD complexes exhibit redundant
and/or distinct functions?
Recombinant CHD3 and CHD4 exhibit distinct, sequence-
specific nucleosome positioning behaviour
In order to analyse whether the respective CHD remodel-
ing enzymes alone already harbour distinct enzymatic prop-
erties, which in turn might lend certain functional speci-
ficity to NuRD complexes in vivo, we compared the chro-
matin remodeling behaviour of the recombinant CHD3 and
CHD4 proteins on various nucleosomal templates (Figure
2 and Supplementary Figures S5A and S7A-D). We found
that in contrast to yeast Ino80, Isw1a or CHD1 (63–65),
CHD3 and as well CHD4 seem to remodel nucleosomes in-
dependent of linker length and the initial position (Figure 2
and Supplementary Figure S7A–C). In line with data from
other remodeling enzymes like dCHD3 and plant PICKLE
(66,67), we observe for both CHD reactions remodeling end
products that migrate below endpositioned (asymmetric)
nucleosomes, arguing for nucleosome species in which less
than 147 base pairs are in contact with the histone octamer
(Figure 2C, lanes 4/7 and Supplementary Figure S7C, lanes
5/9 black asterisks). Comparing the remodeling patterns
between CHD3 and CHD4, we can see that the majority
of final nucleosome positions are the same between CHD3
and CHD4, but the relative nucleosome distributions do
vary and distinct positions do appear (Figure 2A–D lanes
4/7, Figure 2E lanes 5/10 and Supplementary Figure S7A
lanes 5/9, filled and empty triangles and as well intensity
profiles). Nucleosome species, which according to Hamiche
and coworkers (68) correspond to nucleosomes positioned
close to theDNA ends were enriched in the CHD3 remodel-
ing reactions (Figure 2A–D lanes 4/7, Figure 2E lanes 5/10
and Supplementary Figure S7A lanes 5/9, filled and empty
triangles and as well intensity profiles).We therefore suggest
that CHD3 reveals a stronger preference for moving nucle-
osomes to the end of the DNA strand than CHD4.
Since both remodeling enzymes show overall compara-
ble ATP hydrolysis rates and remodeling kinetics (Figure 2
and Supplementary Figure S7A––C, E), we consider the dif-
ferences in the remodeling patterns significant, pinpointing
to distinct remodeler-DNA interactions, resulting in turn in
nucleosome positioning differences.
In living cells, the functional correlation between nucle-
osome repositioning and/or displacement at gene promo-
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
indicates signal, derived from antibody cross reaction). To emphasise a cross reaction signal of the CHD4 antibody, the CHD4 blot of the GFP-IP reactions
(lane 1–3) is presented as a longer exposure (shown in Supplementary Figure S6D). (C) The expression of GFP (control), CHD3-GFP or CHD4-GFP in
stably transfected Flp-In™ T-Rex™ 293 cells was induced by doxycycline treatment for 24 h. Subsequently, whole cell extracts or nuclear extracts (NE) were
prepared and subjected to IP reactions, using GFP Trap® A beads. The reactions were finally analysed by mass spectrometry. A quantitative difference
in protein amount levels is reflected by the emPAI-values (exponentially modified protein abundance index) (121). By reason of clear arrangement we only
present the Mi-2 IP mass spectrometry data, since the control reactions (GFP) either did not show any signal or for the listed proteins or only insufficient
signals according to the quality criteria mentioned inMaterial andMethods. (D) U2OS cells with stably integrated lacO repeats were transiently transfected
with GBP-LacI and the indicated GFP and RFP constructs. 24 hours after transfection, the cotransfected cells were analyzed for colocalization of the
lacO-bound GFP protein and the respective RFP protein via fluorescence microscopy. Scale bar, 2 m (white arrows in the ‘merge picture’ indicate lacO
spots). (E) FCCS measurements performed in U2OS cells transiently transfected with the indicated GFP and RFP constructs. Auto-(AC) and cross-(XC)
correlation functions of the two colour channels are presented as green/red and black curves. Control experiments withGFP andRFP alone or aGFP-RFP
fusion protein were performed to illustrate XC functions in the absence or presence of interactions between GFP and RFP proteins. Number of replicates:
(B) ≥3; (C) 3; (D) (upper panel with CHD3-GFP and CHD4-RFP: 8; lower panel with CHD4-GFP and CHD3-RFP: 5); (E) (RFP,GFP: 5; RFP-GFP: 8;
CHD3-RFP, CHD4-GFP: 24; CHD3-GFP, CHD4-RFP: 15).
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Figure 2. Recombinant CHD3 and CHD4 exhibit distinct, sequence-specific nucleosome positioning behaviour. Recombinantly purified human CHD3/4
were titrated in increasing concentrations (A/C/E: 25, 50, 75 and 100 nM; B/D: 50, 100 and 200 nM) to the indicated mono- and dinucleosomal templates
containing different configurations of linkerDNA (see alsoMaterials andMethods). The reactions were started by addingATP.Nucleosomes in the absence
or presence of enzyme (withoutATP) served as reference. To visualize the nucleosomemovements, the reactions were loaded on PAAgels (ethidiumbromide
stain). Positions of mono- and dinucleosomes are indicated by ovals, according to (68). Filled triangles represent more intense bands, empty triangles less
intense bands or no signal, comparing CHD3 and CHD4 remodeling patterns. Triangles with a dashed rim were added for better orientation in the
intensity profiles (see below). Black asterisks indicate nucleosomes, which were probably pushed over the edge of the DNA strand. On the right side of
each remodeling gel are intensity profiles of the indicated gel lanes, based on Multi Gauge software analysis. The triangles indicate the positions of the
bands highlighted by the triangles in the respective lanes of the corresponding gel picture. All lanes shown for one remodeling template are from one gel.
Number or replicates: (A) ≥3; (B) 3; (C) ≥3; (D) 3; (E) ≥3.
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tors and transcription is well documented in the literature
(69–71). That applies as well for nucleosome remodeling at
DNA ends in regard to DNA repair (72,73). The fact that
CHD3 andCHD4 exhibit distinct remodeling properties al-
ready in the absence of accessory core subunits suggests that
isoform-specific NuRD complexes also possess distinct re-
modeling features and activities regarding the regulation of
DNA dependent processes like repair or transcription.
CHD3 and CHD4 exhibit differential localization patterns
and similar mobility in living cells
To examine whether CHD3 and CHD4 exhibit similar or
different functions in living cells, we decided to use tran-
sient transfection approaches and/or the inducible cell line
system, described above. To compare the localization pat-
tern of both proteins we cotransfected human U2OS cells
with CHD3-GFP and CHD4-RFP (Figure 3).
Both isoforms were enriched in perinucleolar heterochro-
matin and depleted in nucleoli, whereas exclusion from nu-
cleoli was particularly pronounced forCHD4-RFP (see rep-
resentative image in Figure 3A). To quantitatively compare
the localization of both proteins we conducted a colocal-
ization analysis using the pixels within the nucleus. CHD3-
GFP and CHD4-GFP exhibited moderate co-localization
throughout the entire nucleus, which is reflected by the in-
tensity scatter plot in Figure 3B that was created based on
images from several cells. The Pearson correlation coeffi-
cient for the plotted pixels amounted to 0.3 (Figure 3B) and
the intensity correlation coefficient (ICQ) (52) to 0.1 (Figure
3C, top). Pixels in the left quadrants of the covariance plots
in Figure 3C represent positions where one of the CHDpro-
teins is enriched and the other one is depleted, whereas pix-
els in the right quadrants represent positions where both
CHD proteins are co-depleted or co-enriched. The correla-
tion analyses suggest that both proteins colocalize in some
but not all regions of the nucleus, consistent with the im-
ages shown in Figure 3A. Notably, the probability to ob-
tain this ICQ value for two completely independent distri-
butions is very low (P< 0.001, seeMaterials andMethods),
indicating that the localization patterns of CHD3-GFP and
CHD4-RFP share significant, but only limited similarity.
When considering only pixels within nucleoli, a similar but
slightly lower ICQ value was obtained (Figure 3C, bottom).
Notably, we observed a distinct subpopulation of pixels co-
inciding with CHD3-GFP enrichment and CHD4-RFP de-
pletion in nucleoli (top left quadrant of the covariance plot),
corroborating the finding that CHD4 is stronger depleted in
nucleoli than CHD3.
Next, we compared the nuclear mobility parameters
of CHD3 and CHD4 based on the FCCS measurements
shown in Figure 1E and Supplementary Figure S6E. Both
CHD3- and CHD4-containing NuRD complexes exhibited
similar effective diffusion coefficients (Supplementary Fig-
ure S6E), which are comparable to those found for other re-
modeling enzymes in U2OS cells (47). This result suggests
that a large fraction of NuRD complexes samples chro-
matin in transient binding interactions rather than being
stably tethered to their target sites.
Figure 3. CHD3 and CHD4 exhibit differential nuclear localization pat-
terns. (A) Representative image of a living U2OS cell transiently trans-
fected with CHD3-GFP and CHD4-RFP. Both proteins were enriched
in perinuclear heterochromatin. CHD4-RFP was more strongly depleted
in nucleoli than CHD3-GFP. Scale bar, 2 m. (B) Scatterplot for GFP-
and RFP signals in the same cells. A Pearson correlation coefficient of r
= 0.3 was obtained, indicating moderate co-localization. Fifteen images
were analyzed. (C) Covariation analysis for the data in panel B. The in-
tensity correlation quotient (ICQ) value of 0.1 within the whole nucleus
suggests partial but significant co-localization (psign test < 0.001) of both
proteins (top). A similar result was obtained if only pixels within nucleoli
were considered (bottom). In the latter case, we observed a subpopulation
of pixels with anti-correlated signals, which reflects nucleolar regions in
which CHD3 was enriched and CHD4 was depleted. An anti-correlated
subpopulation of pixels was present, which reflects CHD3 enrichment and
CHD4 depletion. Fifteen images were analysed.
CHD3 and CHD4 are recruited to laser-induced DNA dam-
age sites
Several chromatin remodelers are recruited to laser-induced
DNA damage sites, which contain pyrimidine dimers and
DNA intrastrand cross-links (47,74–77). Recent studies in
mammalian cells reported a deviance of CHD3/4-NuRD
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Figure 4. CHD3 and CHD4 are rapidly recruited to laser-induced DNA
repair sites and interact with HP1. (A) U2OS cells transiently expressing
complexes in the repair of DNA damage (78–81). Here,
we compared the behaviour of CHD3- and CHD4-GFP
upon laser-treatment of U2OS cells. In these experiments,
cotransfected RFP-tagged HP1-alpha (CBX5), which has
been shown to be recruited to laser-induced damage sites
(76,82) served as a positive control (Figure 4A and B).
Both CHD3 and CHD4 accumulated at laser-induced le-
sions (Figure 4A), with association kinetics comparable to
each other and to HP1-alpha (Figure 4B). HP1-alpha and
NuRD are localized to pericentric heterochromatin (83–
86) and HP1-IP reactions revealed that HP1-alpha copre-
cipitates with CHD4 (87), whereas HP1-beta (CBX1) and
gamma (CBX3) coprecipitate with CHD3 and CHD4 (85).
This prompted us to examine immunoprecipitation reac-
tions of CHD3- and CHD4-GFP for the presence of the
different HP1 isoforms (Figure 4C). In western blot experi-
ments we found that all three HP1 isoforms were associated
with both CHD3- and CHD4-GFP in the context of NuRD
in the absence of DNA damage (Figure 4C, lane 2 and 3).
Mass spectrometry analyses of CHD3- and CHD4-GFP-
IP samples showed a clear coprecipitation of HP1-gamma
with both Mi2-isoforms and also suggest a coprecipitation
of HP1-beta (Figure 4C, table). We even successfully ver-
ified the interaction of Mi-2 proteins with HP1 proteins
on endogenous protein level, by detecting HP1-gamma and
HP1-beta in western blots of Mi-2-IP reactions (Figure 4D,
lane 2). Since we still see a coprecipitation of endogenous
HP1-beta and gamma with endogenous Mi-2 in the pres-
ence of Benzonase or Ethidium bromide (Figure 4D, lane
7 and Supplementary Figure S5E), we propose that the in-
teraction is not DNAmediated (88,89). Taken together our
IP data and the colocalization of HP1 and NuRD in peri-
centric heterochromatin and at laser-induced DNA lesions
suggest a functional connection between both CHD pro-
teins and HP1.
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
HP1-RFP and CHD3/4-GFP were subjected to localized microirradia-
tion with a 405 nm laser. CHD3-GFP, CHD4-GFP and HP1-RFP accu-
mulated at the damage site (gray circles). Radial intensity profiles around
the damage site are shown below the images for clarity. Scale bar, 2m. (B)
Accumulation kinetics of the indicated constructs at the damage site. (C)
The expression of GFP (control), CHD3-GFP or CHD4-GFP in stably
transfected Flp-In™ T-Rex™ 293 cells was induced by doxycycline treat-
ment for 24 h. Subsequently, (i) whole cell extracts (WCE) and (ii) nuclear
extracts (NE) were prepared and subjected to IP reactions, using GFP-
Trap® A beads. The IP reactions were finally analysed by (i) western blot
with the indicated HP1 antibodies or (ii) mass spectrometry. The reac-
tions were finally analyzed bymass spectrometry. A quantitative difference
in protein amount levels is reflected by the emPAI-values (exponentially
modified protein abundance index) (121). (*) Only one unique peptide was
found in the mass spectrometry analysis (see alsoMaterials andMethods).
(D) Nuclear extract (NE) from non-transfected Flp-In™ T-Rex™ 293 cells
was prepared and subjected to IP reactions in the absence or presence of
Benzonase (see alsoMaterials andMethods), using ProteinA beads (+Mi-
2 antibody or no antibody as control). The IP reactions were finally anal-
ysed by western blot with the indicated HP1 and Mi-2-NuRD antibodies.
Number of replicates: (A/B) (left) CHD3-GFP and HP1-alpha-RFP (12);
(right) CHD4-GFP and HP1-alpha-RFP (12); (C) 3; (D) 3.
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CHD3 andCHD4 exert common and distinct gene regulatory
functions
The differences in intranuclear localization and the differ-
ences in the remodeling behaviour found above for CHD3
and CHD4 might reflect distinct activities in different ge-
nomic regions with a putative effect on gene activity. We
were therefore interested to examine if CHD3 and CHD4
are responsible for the regulation of different genes, since
chromatin remodeling enzymes are involved in the control
of various DNA-dependent processes like transcription (5).
Analysing RNA-seq data of two independent (total) RNA
preparations fromdoxycycline-induced (24 hours) and non-
induced Flp-In™ T-REx™ 293 cells (Supplementary Figure
S3) via DESeq revealed 16 (i) and 115 (ii) distinctly regu-
lated genes when CHD3-GFP (i) and CHD4-GFP (ii) were
overexpressed, respectively (Figure 5A and B and Supple-
mentary Figure S8: black/blue labelled gene names). Nine
genes are equally influenced by both types of NuRD com-
plexes (Figure 5A and Supplementary Figure S8: red la-
beled gene names). TheRNA-seq analysis furthermore sug-
gests that almost the same number of genes is up- and down-
regulated in the presence of exogenous CHD3 and CHD4
(Figure 5A, B and Supplementary Figure S8). These find-
ings are somewhat surprising, sincemost of the publications
describe NuRD in the context of transcriptional repression
(37,39).
We validated the RNA-seq results via quantitative PCR
(qPCR) with cDNA from three new (independent) doxy-
cycline inductions. The alterations in gene expression, de-
termined by our qPCR experiments, were comparable to
those from the RNA-seq analysis (Figure 5B, C and Sup-
plementary Figure S8). We found four genes that are pre-
dominantly regulated by either CHD3 or CHD4: ZNF467
was upregulated by CHD3-GFP (Figure 5C), RGS19 and
USE1 were upregulated by CHD4-GFP and SUMO3 was
downregulated by CHD4-GFP (Figure 5C).
Taken together our data therefore suggest that NuRD
complexes either contain CHD3 or CHD4 as a motor
subunit. We furthermore postulate that the two remodel-
ing enzymes are associated with the NuRD complex as
monomers. Our data in vitro and in living cells reveal that
CHD3 or CHD4 comprising NuRD complexes exert simi-
lar and as well distinct functions (Figure 6).
DISCUSSION
Approximately twenty years ago, the purification and bio-
chemical characterization of a large macromolecular com-
plex, coupling chromatin remodeling properties with hi-
stone deacetylase function was reported simultaneously
by several laboratories (33–36). This complex, named
Mi-2 NuRD, contains several repressors like HDAC1/2,
MTA2/3 orMBD2/3 and CHD3/4 [Mi-2 subfamily] as the
motor subunit (38). The composition of this complex seems
to vary upon distinct physiological circumstances and it is
still matter of debate whether CHD3 and CHD4 coexist in
the same complex or not (37,38). CHD3 and CHD4 are
highly identical in their amino acid sequence (Figure 1A
and Supplementary Figure S1). Therefore the functional
characterization of this complex in vivo is difficult, since
many molecular biological and biochemical detection tools
only allow a statement about the two Mi-2 representatives
in general. Since many studies in the past focused only on
one of the two Mi-2 isoforms, the question about potential
structure-function relationships remained enigmatic. Here,
we shed light on this question by comparing both Mi-2 iso-
forms in four different types of experiments: (i) We showed
in living cells that the presence of CHD3 and CHD4 in
NuRD ismutually exclusive. (ii) Somewhat surprisingly, not
only CHD4 but also CHD3 accumulated at sites of DNA
damage. (iii) CHD3 and CHD4 have distinct regulatory
functions for gene expression as inferred from a comparison
of their target genes. (iv) The detailed analysis of CHD3 vs.
CHD4 showed an overall similar activity with small but sig-
nificant differences in their enzymatic translocation proper-
ties.
CHD3 and CHD4 exist in distinct NuRD complexes
Several mammalian remodelers like Snf2h [Iswi subfamily]
(47) and yeast Fun30 [Etl1 subfamily] (90) tend to form
homodimers (or higher-order complexes), which raises the
questions if the closely related CHD3 and CHD4 proteins
act as homo- and/or heterodimers in NuRD complexes of
living cells. Using different biochemical and microscopy-
based techniques we clearly demonstrate here that CHD3
and CHD4 do not tend to self-associate in living cells
(Figure 6 and Supplementary Figure S6B–D). Rather, our
data suggest that cells contain isoform-specific NuRD com-
plexes, supporting previous findings of (36) and (11) (Fig-
ures 1B-E and 6 and Supplementary Figure S4). Interest-
ingly, a NuRD-like complex with CHD5 [Mi-2 subfamily]
as the motor subunit did not show a coexistence of the
closely related enzymes CHD5 and CHD3/4 in the same
complex (91,92). Consistently, our mass spectrometry anal-
yses also argue for the presence of only one CHD type per
NuRD complex (Figures 1C and 6 and Supplementary Fig-
ure S4). In line with this, Bergs and colleagues (93) showed
that CHD3/4 and CHD5 have different expression patterns
in mouse testis and brain, whereupon CHD3/4 and CHD5
are expressed in amutually exclusivemanner in adultmouse
testis.
By contrast, remodelers from other subfamilies seem to
interact with CHD3/4 NuRD complexes. The mass spec-
trometry and western blot data showed a noticeable enrich-
ment of Brg1 and Snf2h signals in the CHD-IP reactions in
comparison to the control reaction (Figure 6 and Supple-
mentary Figures S4 and S9). These findings are in line with
data from (26,94,95). Thus, the presence of two remodeling
enzymes from different subfamilies within one NuRD com-
plex might provide sufficient functional complexity without
requiring a coexistence of CHD3 and CHD4. In this regard
it is interesting to note that Morris and coworkers (96) per-
formed ChIP-seq and DNase I-seq experiments arguing for
a co-occupancy of mouse Brg1, CHD4 and Snf2h at certain
genomic loci, where they act to some extent synergistically.
Beside Brg1 and Snf2h, we confirmed that HP1 is a sub-
unit that is also shared among CHD3- and CHD4 contain-
ingNuRDcomplexes (Figures 4C,D and 6 and Supplemen-
tary Figure S4). To our knowledge, we are the first to show
a DNA-independent interaction of Mi-2 and HP1 proteins
on endogenous protein level (Figure 4Dand Supplementary
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Figure 5. CHD3/4 containing NuRD complexes regulate distinct genes in living cells. Stably transfected Flp-In™ T-Rex™ 293 cells were incubated in the
absence (non-induced) or presence (induced) of doxycycline for 24 h. Five independent sets of total RNA were prepared. Two sets of total RNA were
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Figure S5E), suggesting a functional connection between
the two proteins (Figure 4). Interestingly, Sun et al. (97) pro-
pose a coregulation of SOX9 gene transcription by HP1-
beta (CBX1), CHD4 and KAP-1 (TRIM28) on the basis of
consecutive ChIP experiments.
Finally, our mass spectrometry and western blot analy-
ses predominantly detected shared core subunits and shared
interacting partners (Figures 1B,C and 4C,D and Supple-
mentary Figures S4 and S9), but no (new) isoform-specific
binding protein. In line with this, there are primarily ‘shared
binding partners’ documented in the literature. Regarding
the high degree of similarity betweenCHD3 andCHD4 and
the small unique amino acid region in CHD3, representing
a putative binding platform for specific interaction partners
(Figure 1A and Supplementary Figure S1), these findings
don’t appear too surprising. To our knowledge, KAP-1 is so
far the only verified binding protein, that exclusively inter-
acts with hCHD3 in its (mostly unique) C-terminal amino
acids 1909–2000 (Figures 1A and 6 and Supplementary
Figure S1 and (11)). Interestingly we could detect KAP-1
in CHD3 and as well CHD4-IP-reactions (Supplementary
Figure S4), which might be explained by the use of different
IP protocols and cell lines. For CHD4, no specific interac-
tion partner has been published until now.
CHD4 and as well CHD3 accumulate at sites of DNA dam-
age
The complex interplay between common and specific bind-
ing partners could explain why CHD3 and CHD4 are in-
volved in the same, similar or distinct intracellular processes
(Figure 6). Even though both Mi-2 isoforms seem to ex-
hibit opposite interaction behaviour regarding heterochro-
matic DSBs (induced by ionizing radiation), which is me-
diated by KAP-1 (78–81), we do not observe the same for
laser-induced DNA damage in human U2OS cells (Figure
4A, B). Surprisingly, this kind of DNA damage resulted in
the recruitment of both, CHD3- and as well CHD4-NuRD
complexes to the damage sites (Figure 4A, B), an obser-
vation which might be explained by the fact that we in-
duced DNA damage in a different way and within bona
fide euchromatin. Our Co-IP data moreover suggest that
HP1 and CHD proteins might be recruited to the damage
sites in the context of a common (NuRD) complex (Figures
1B, C and 4C, D and Supplementary Figure S4). Interest-
ingly data from (98) and (99) suggest that the recruitment of
CHD4/NuRD and as well HP1 to DNA damage sites de-
pends onPARP (Poly (ADP-ribose) polymerase) activity. In
contrast to HP1, both CHD proteins and their Drosophila
homologue Mi-2 seem to possess a conserved PAR bind-
ing motif (99–101). In case of CHD4 this motif seems to
span the first N-terminal 360 aa and seems to form a HMG
box like structure which is important for directing the re-
modeling enzyme to DSB sites (101). Therefore, associa-
tion of CHD3/4 with PARylated chromatin might promote
binding of the NuRD-HP1 complex to DNA lesions. Inter-
estingly, HP1 also interacts with other proteins that accu-
mulate at DNA lesions, e.g. Brg1 and Acf (75,76,102–104).
Taking into account our Co-IP data, showing an interac-
tion of Brg1 and Snf2h (the catalytic subunit of the ACF
complex) with CHD containing NuRD complexes (Figures
1B, C and 6 and Supplementary Figures S4 and S9), one
could speculate whether the CHD3/4 mediated recognition
of PARylated chromatin might also play a role for binding
of these factors to DNA damage sites.
CHD3 and CHD4 showed small but significant differences in
their enzymatic translocation properties
Beside common or unique binding partners, our data sug-
gest that intrinsic remodeling properties have also to be
taken into account as an important factor influencing the
functional properties of CHD-containing chromatin re-
modeling complexes (Figures 2 and 6 and Supplementary
Figure S7A). Several in vitro studies, comparing remodel-
ing enzymes representing distinct subfamilies, revealed ob-
vious disparities in the qualitative remodeling behaviour of
those proteins (6,105). Furthermore those enzymes exhib-
ited distinct stimulation properties by features like DNA
linker length or histone tails concerning their ATPase ac-
tivity (6,105). In the light of these findings it is therefore in-
teresting to note that we even observed differences in the
nucleosome positioning between CHD3 and CHD4 (Fig-
ure 2 and Supplementary Figure S7A), which belong to the
same subfamily [Mi-2] (7) and exhibit moreover a high de-
gree of identity in the known functionally relevant motifs
(Figure 1A and Supplementary Figure S1 and (11)). The
fact that the observed differences in nucleosome position-
ing already occur in the absence of potentially regulatory
NuRD subunits (Figures 2 and 6 and Supplementary Fig-
ure S7A) shows that they are intrinsic to the remodeling
enzymes themselves. Assuming that CHD3- and CHD4-
NuRD complexes move nucleosomes in vivo to distinct po-
sitions would provide an attractive mechanism for how the
balance of both proteins affects the accessibility or inac-
cessibility of DNA regions for regulatory factors, like for
example transcription factors. This emphasizes the idea of
CHD nucleosome remodelers (and nucleosome remodelers
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
subjected to Illumina Sequencing (A and B): differential gene expression was analysed using the DESeq2 R package (59). Samples without doxycycline
induction were considered as ground state and differential expression was determined by a false discovery rate below 0.1. (A) The table presents the total
number of specifically and commonly up- (↑) and downregulated (↓) genes upon CHD3/4 expression (* the number of specifically upregulated genes does
not include the upregulated CHD3/4 genes due to doxycycline treatment). (B) MA-plots illustrate log2 fold changes (y-axis) for each gene in comparison
to the average count (x-axis). The red points indicate differentially expressed genes determined by DESeq2 analysis (FDR< 0.1), including the doxycycline
induced CHD3/4 proteins. (C) The other three sets of total RNA were reversely transcribed into cDNA for qPCR experiments: Data were collected by
the Rotor-Gene 3000 system, analyzed using the comparative analysis software module and presented as relative expression values, using Lamin A/C
for normalization. The mean values and standard deviations are derived from three biological replicates (with at least two technical replicates for each
biological replicate). Relative expression values for induced (+dox) and non-induced (–dox) conditions were tested for significance using a two tailed,
homoscedastic t-test in Microsoft Excel. P-values are given for sets with significant changes (*P < 0.05, **P < 0.01, ***P < 0.001). Number of replicates:
(A/B) 2 (see above); (C) 3 (see above)→ in total: five independent total RNApreparations (see above). The raw data for the RNA-seq analysis are deposited
in the GEO database (accession number: GSE93543).
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Figure 6. CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. Our experiments propose that CHD3 and CHD4
form isoform-specific NuRD complexes in living cells, harboring one single copy of the respective remodeling enzyme. Beside well known ‘shared’ core
subunits like HDAC1/2 orMTA2/3 proteins, we found Brg1, Snf2h and HP1 to be associated with both CHD3- and CHD4-containing NuRD complexes.
DNA damage experiments, performed in this study, suggest that both CHD3- and CHD4-containing NuRD complexes exert a role in the DNA damage
response. Nevertheless, an individual role of mouse CHD3 in DSB repair was proposed by the CHD3 specific binding protein KAP-1 (11,81). In addition
to interaction partners that might act as functional NuRD regulators, we propose intrinsic remodeling properties as another possibility to influence
the physiological role of NuRD complexes in vivo. Nucleosome remodeling assays with recombinant, single CHD3 and CHD4 proteins revealed that
both enzymes move nucleosomes to distinct, sequence-specific positions, supporting the idea of CHD remodeling enzymes acting as chromatin specific
organizers. In line with this, we observe mainly distinct nuclear localization patterns for CHD3- and CHD4-NuRD complexes in living cells, arguing for
the existence of structurally and spatially separated complexes acting independently from each other in different genomic regions with a putative effect on
gene activity. Indeed, our RNA-seq and qPCR experiments showed that CHD3 and CHD4mainly regulate distinct genes. Taken together our data suggest
that CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality (see also Results and Discussion).
in general) acting as functionally specific chromatin orga-
nizers, as favoured by (70,106–108). Indeed, chromatin re-
modeling enzymes from three different subfamilies, namely
Snf2h (NoRC) [Iswi], CSB [ERCC6] and CHD4 (NuRD)
[Mi-2] seem to regulate the transcription status of mam-
malian rDNA genes via distinct nucleosome repositioning
at the rDNA promotor (7,70,109–111). Interestingly, we
also observe differences in the remodeling pattern between
CHD3 and CHD4 on the drosophila HSP70 and the mouse
rDNA promotor sequence (Figure 2D and Supplementary
Figure S7A).
CHD3 and CHD4 have distinct regulatory functions for gene
expression
The aspect of CHD chromatin remodelers acting as func-
tional specific chromatin organizers is furthermore sup-
ported by our fluorescence microscopy data (Figure 3).
Transient transfections in U2OS cells show that CHD3 and
CHD4, being coexpressed in one cell, share significant but
only limited similarities in their nuclear localization pat-
terns. Both were enriched in perinucleolar heterochromatin,
but CHD4 seemed to be stronger depleted in nucleoli than
CHD3 (Figure 3). Consistently, immunocytochemical ex-
periments (human protein atlas) performed with antibod-
ies directed against the endogenous proteins in U2OS, A-
431, U-251 MG and HeLa cells, solely ascribe a nucleo-
lar localization to CHD3, not to CHD4 (112–115). These
differential localization patterns for CHD3 and CHD4 ar-
gue for the existence of structurally and spatially separated
complexes acting independently from each other in differ-
ent genomic regions with a putative effect on gene activity.
Indeed, our RNA-seq and qPCR data reveal that the ma-
jority of expression changes concerns genes which seem to
be under the control of one particularMi-2 isoform (Figure
5A, C and Supplementary Figure S8): The opposite isoform
either shows insignificant effects compared to the GFP con-
trol or, in some cases, subtle synergistic effects (Figure 5C).
In this context it is interesting to note that recent studies,
performed in G1E-ER-GATA-1 cells and 0308 TICs, for-
tify our RNA-seq and qPCR experiments by attributing a
regulatory function onRGS19 and SUMO3 gene transcrip-
tion to CHD4 as well (116,117). However, while we found
that RGS19 was up- and SUMO3 was downregulated by
CHD4 overexpression, (116) and (117) report the opposite
regulation of these genes by CHD4. This discrepancy might
be explained by the different cellular environment. Further-
more, ChIP-seq experiments in TICs showed that CHD4 is
associated with the USE1 gene, a gene which we found up-
regulated by CHD4 (117).
Our RNA-seq data also give reason to reconsider our
view on NuRD acting predominantly as a transcriptional
repressor (37–39). The definition of NuRD as transcrip-
tional silencer mainly derives from the fact that many core
subunits are associated with transcriptional repression and
that many studies only focused on certain sets of genes or
even single gene analysis (37–39,97). To our knowledge we
are the first to present a comparative (general) screen of
genes, regulated by WT Mi-2 proteins (Figure 5 and Sup-
plementary Figure S8). Since we observe nearly the same
number of genes up- and downregulated in the presence of
CHD3 and CHD4 (Figure 5A,B and Supplementary Fig-
ure S8), we suggest that NuRD rather functions equally as
a transcriptional activator and silencer.
Furthermore our RNA-seq analysis shows that the
amount of CHD4 regulated genes seems to be nearly seven
times higher than the number of CHD3 regulated genes
(Figure 5A,B and Supplementary Figure S8). Looking at
the same time at the endogenous expression levels of (hu-
man and mouse) Mi-2 proteins in vivo, an imbalance of the
expression levels in favour of CHD4 becomes obvious: De-
spite the coexpression of both Mi-2 proteins in many tis-
sues, CHD4 very often reaches higher expression levels than
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CHD3 (Supplementary Figure S2) and (118,119). Accord-
ingly, we also observe more endogenous CHD4 than CHD3
transcripts in our Flp-In™ T-REx™ 293 cells (Supplemen-
tary Figure S10A). Taken together, the expression level dis-
equilibrium - even though we modulate it by overexpressing
CHD3 or CHD4 (Supplementary Figure S10A,B) - and the
higher amount of CHD4 regulated genes (Figure 5A,B and
Supplementary Figure S8) might argue for a dominant role
of CHD4 over CHD3 regarding transcription regulation.
Concluding remarks
In mouse thymus CHD3 levels increased upon CHD4
knockdown, whereas the rest of the NuRD core subunits
remained unaffected (119). Interestingly, we see a decrease
of endogenous CHD4 mRNA levels upon induction of
CHD3-GFP in our RNA-seq data (Supplementary Figure
S8). Similar observations were made for the highly identical
proteins Snf2h and Snf2l. Data from (embryonic) mouse ex-
periments showed that a time-specific loss of Snf2h seems to
be compensated by rising amounts of Snf2l (reconstituting
amongst other parameters En1 mRNA levels) (7,32). One
could therefore speculate that the coexpression of both Mi-
2 proteins might serve the following purpose: CHD3, due
to its high similarity and the partially redundant functions,
might be able to replace CHD4 to some extent (and vice
versa). On the other hand, our data argue that the coex-
istence of CHD3- and CHD4 proteins in many cells might
originate from the partly functional difference between both
remodelers (Figure 6).
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